India's New IT Policy Aims for Broader Growth
India's revised IT policy shifts focus from hardware manufacturing to broader digital ecosystem development, aiming to create a more inclusive and sustainable technology sector by 2027.
India's revised IT policy shifts focus from hardware manufacturing to broader digital ecosystem development, aiming to create a more inclusive and sustainable technology sector by 2027.
Dixon, Tata Electronics, and other Indian manufacturers are aggressively expanding into component manufacturing through acquisitions and JVs to boost thin margins. India's electronics production is projected to hit ₹44 trillion by 2030.
Phillips Machine Tools inaugurates a world-class Manufacturing Expertise Center in Chakan, Pune, accelerating India's transition to smart, sustainable manufacturing. Explore the future of industry today!
Tragic boiler explosion at pharmaceutical factory in Bharuch's Saykha GIDC leaves 2 workers dead, 20 injured. Fire brigade and investigation teams on site. Read latest updates.
Tragic boiler explosion at pharmaceutical factory in Gujarat's Bharuch district claims 2 lives, leaves 20 injured. Massive fire brought under control by emergency teams.
The FDA appoints veteran cancer regulator Dr. Richard Pazdur to lead its drug center following the ouster of Dr. George Tidmarsh over ethics concerns. Learn about the challenges ahead.
Granules Life Sciences receives USFDA approval for new Hyderabad facility to manufacture diabetes drug Metformin HCL. Capacity: 10 billion tablets annually. Read more about this pharmaceutical milestone.
Discover how Pune's Rawmart evolved from steel supplier to a full-stack partner for SMEs, offering credit, tech, and production support to fuel India's economic ambition.
DCGI directs state authorities to enforce strict GMP compliance by December 31, 2025. Delhi, Himachal Pradesh, Uttarakhand already taking action against non-compliant manufacturers.
India's drug regulator DCGI mandates global manufacturing standards for all pharma companies by January 2026. State regulators ordered to begin inspections immediately. Read about the strict compliance requirements.
Sun Pharma investors await Q2 FY26 results with cautious optimism as US tariff clarity emerges. Discover how import duties and market dynamics could impact India's pharmaceutical giant.
Curis Lifesciences' NSE SME IPO witnesses massive investor response with 17.36 times subscription on Day 1. Discover GMP trends, price band details, and why this pharma stock is creating buzz.
India's manufacturing sector faces significant hurdles in repeating its previous success story. Explore the global economic shifts, domestic infrastructure gaps, and policy challenges threatening the next industrial revolution.
Tata Sons invests over $1.3 billion in electronics business, becoming key Apple iPhone supplier and transforming India's manufacturing landscape with strategic acquisitions.
A high-stakes White House meeting on weight-loss drug prices took a dramatic turn when a pharmaceutical executive suddenly collapsed, forcing an abrupt end to Donald Trump's briefing. The viral video has sparked nationwide concern.
Former President Donald Trump reveals groundbreaking agreement with pharmaceutical giants to dramatically reduce costs of popular weight loss medications, promising relief for millions struggling with obesity.
In a major victory for American patients, pharmaceutical titans Eli Lilly and Novo Nordisk announce significant price reductions for popular weight-loss medications after Trump's intervention.
Indian pharmaceutical companies are reporting exceptional earnings driven by US generic drug sales, leading to major fundraising initiatives for expansion into medtech and wellness sectors.
GlobalFoundries India showcases groundbreaking India Foundry Connect initiative, strengthening collaboration with fabless companies and accelerating semiconductor innovation at Teknika 2025.
British-Swedish pharma giant AstraZeneca reports blockbuster Q3 results with profits surging 77% to $2.53 billion, driven by robust cancer drug sales and strategic US market expansion.
Piramal Pharma anticipates significant growth as US biopharma funding shows recovery signs, with CDMO business poised for major expansion.
In a significant crackdown, the Directorate of Revenue Intelligence dismantled a sophisticated drug factory in Gujarat's Valsad district, seizing massive quantities of Alprazolam worth crores and arresting key operatives.
Danish pharmaceutical giant Novo Nordisk faces turbulent times as Q3 profits drop 27% despite Ozempic's success. The company announces massive restructuring with 9,000 job cuts worldwide. Get the inside story on what's happening behind the scenes.
Roshni Renewable LLP announces Punjab's first giga-scale solar manufacturing facility with 1.2 GW capacity, creating 1,000+ jobs and boosting India's green energy infrastructure.
Solara Active Pharma Sciences faces challenging quarter with ₹10 crore net loss despite revenue growth. Discover the operational challenges and management's recovery strategy.
India's pharmaceutical giant Sun Pharma reports steady Q2 growth with 9% revenue increase while navigating US market challenges. Key insights from their latest earnings report.
Tata Electronics partners with Powerchip to establish India's pioneering silicon carbide semiconductor facility in Odisha, marking a significant milestone in the country's electronics manufacturing ecosystem.
Discover how AgentForce's AI-powered platform is reshaping customer engagement in India's life sciences sector, eliminating burnout while boosting productivity by 40%.
Himachal Pradesh drug control authorities raid Baddi pharmaceutical facility after Rajasthan complaints reveal distribution of sub-standard medicines across seven districts, raising serious public health concerns.
Hyderabad-based Azad Engineering secures strategic partnerships with aviation giants Rolls-Royce and Boeing, positioning India as global aerospace manufacturing hub.